BiotechTube
Home/Immatics Biotechnologies/Toni Weinschenk, Ph.D.
TW

Toni Weinschenk, Ph.D.

Chief Innovation Officer

Immatics Biotechnologies

Roles

Chief Innovation OfficeratImmatics Biotechnologies
Chief Innovation OfficeratImmatics

Therapeutic Areas

OncologySolid Tumors

Immatics Biotechnologies Pipeline

DrugIndicationPhase
IMA203PRAME-positive solid tumorsPhase 1/2
IMA203CD8PRAME-positive solid tumorsPhase 1/2
IMA402PRAME-positive solid tumorsPhase 1/2
IMA204Undisclosed solid tumorsPhase 1

Leadership Team at Immatics Biotechnologies

HS
Harpreet Singh, Ph.D.
Chief Executive Officer
CB
Cedrik Britten, M.D.
Chief Medical Officer
CR
Carsten Reinhardt, M.D., Ph.D.
Chief Development Officer
SW
Steffen Walter, Ph.D.
Chief Operating Officer
VR
Venkat Ramanan, Ph.D.
Chief Financial Officer
RK
Rainer Kramer, Ph.D.
Chief Business Officer & Site Head Munich
ES
Edward Sturchio, J.D.
General Counsel
PC
Peter Chambré
Chairman of the Board of Directors
HL
Heather L. Mason
Vice Chair of the Board of Directors
View full Immatics Biotechnologies profile